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CC BY-NC-ND license (http://creativeAbstract Beta catenin has been well documented in previous studies to be involved in non
small cell lung cancer (NSCLC). Beta catenin abundance and transcriptional activity are signif-
icantly regulated by several factors. Though it is well known that Akt and Gsk3 beta are respec-
tive positive and negative regulators of beta catenin, however, no single study has so far
documented how the expression and activity of both positive as well as negative regulators
play favorable role on beta catenin expression and activity in NSCLC. In this study, we
compared expression and activity of beta catenin and its regulators in normal lung cell WI38
and NSCLC cell A549 by western blot, qRT-PCR and luciferase assay. We observed that beta ca-
tenin positive regulators (Akt and Hsp90) and negative regulators (Gsk3 beta and microRNA-
214) have differential expression and/or activity in NSCLC cell A549. However the differen-
tially altered statuses of both the positive and negative regulators rendered cumulative posi-
tive effect on beta catenin expression and activity in A549. Our study thus suggests that
chemotherapeutic modulations of regulating factors are crucial when abrogation and/or inhi-
bition of key oncogenic proteins are necessary for cancer chemotherapy.
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Non small cell lung cancer (NSCLC) is a group of lung can-
cers that are named for the types of cells affected and their
morphology under the microscope. NSCLCs account for 85%
of all the cases of lung cancers.1 NSCLCs are relatively
chemo-resistant, with respect to small cell lung cancer
(SCLC).
Beta catenin is an oncogenic protein that is pivotal for
the expression of Wnt responsive genes2e6 which regulate
proliferation, cell division, anti-apoptosis, angiogenesis,
metastasis and is consequently necessary for carcinogenesis
and cancer progression. In NSCLC, beta catenin mutations
are extremely uncommon.7,8 But, the relationship between
aberrant beta catenin expression and NSCLC poor prognosis
is well documented.9,10 Beta catenin was previously shown
to be important for proliferation, migration and clonogenic
ability of A549 NSCLC cell.11 Hence, beta catenin status in
terms of its expression and activity is of immense impor-
tance in NSCLC.
Cellular abundance and transcriptional activity of beta
catenin are regulated by multiple positive and negative
regulators. Since, beta catenin has been demonstrated to
be involved in NSCLC, the expressions and activities of key
beta catenin regulators may have some crucial contribution
in NSCLC. So far no single study has shown how the
expression and activity of positive as well as negative reg-
ulators of beta catenin are altered in NSCLC and how they
have overall effect on beta catenin. Hence, we studied
whether the expression and activity of known regulators of
beta catenin are modulated in NSCLC cell that could be
beneficial for beta catenin abundance and transcriptional
activity. We observed that, besides beta catenin upregu-
lation, well known positive regulators of beta catenin like
Akt & Hsp90 and negative regulators like Gsk3 beta and
microRNA-214 (miR-214) are differentially modulated in
A549 NSCLC cell that had overall positive effect on beta
catenin expression and transcriptional activity.Materials and methods
Antibodies and chemicals
A list of antibodies and other chemicals used in this study is
given in Supplementary Table S1.
Cell culture, drug treatment and transfection
Normal lung cell WI38 (Gifted by Dr. Mahadeb Pal, Bose
Institute, India) and NSCLC lung cancer cell A549 (obtained
from National Centre For Cell Science, India) were cultured
in DMEM supplemented with 10% Fetal Bovine Serum and
incubated at 37 C in a humidified incubator supplied with
5% CO2. Cells were treated with 500 nM 17AAG or vehicle
(DMSO) and incubated for 48 h. For transfected cells to be
used in western blot or real time qRT-PCR, cells were split
in 60 mm dishes and were transfected with 3 mg pRNA-U61/
Hygro empty vector (empty U61) control or 3 mg pRNA-U61-
pre-miR-214 (miR-214-U61) and incubated for 72 h. 10 ml
Lipofectamine 2000 was used per dish as transfectionreagent. Throughout all the experiments passage number
varied between 5th to 26th for WI38 cells and between 3rd
to 18th for A549 cells. For every experiment it was ensured
that cells had been passaged at least thrice after thawing.
Sub-cellular extraction
Both cytosolic and nuclear extractions were performed as
described.12 Cells were fractionated after 48 h of plating
when they reached w90% confluency.
Western blot
All western blotting experiments were done in this study as
per our previous work.13 Untreated/untransfected cells
were harvested at 48 h after plating when they reached
w90% confluency. 17-AAG treated and empty-U61 or miR-
214-U61 transfected cells were harvested after 48 h of
incubation.
RNA isolation, cDNA preparation and real-time
quantitative PCR
Cells were harvested at w48 h after plating when they
reached w90% confluency or harvested at 48 h after
transfection with empty U61 and miR-214-U61. To study the
expression of mRNAs viz. CTNNB1, GSK3B, AKT1, MYC,
CCND1, JUN, FOSL1, BIRC5, ACTB (reference gene), the
same reagents and same RNA isolation, cDNA preparation,
real time qPCR techniques were used as per our previous
work.13 For miRNA expression study, the use of U6 snRNA as
reference gene has been well validated.14 100 ng of RNA
was reverse transcribed into cDNA with MuLV-Reverse
Transcriptase and stem-loop primer for miR-214 and U6
snRNA and then subjected to real time qPCR using SYBR
green mastermix on Mastercycler Ep Realplex (Eppendorf,
Germany) using the forward primers of miR-214, U6 snRNA
and universal reverse primer. Ct value of target (miR-214)
was normalized to Ct value of reference (U6 snRNA).
2LDDCt method was used to calculate the fold change in
miR-214 expression. A list of sequences of the primers used
in this study is added in Supplementary Table S2.
Luciferase assay
Luciferase assays were performed with same principle and
method as described previously by us.13 Briefly, 200 ng
TOPFLASH TCF-reporter plasmid was transfected in cells
grown in 24 well plates and then incubated for 24 h and 48 h
respectively and then harvested for experiments. 5 mg ly-
sates from incubated samples were subjected to luciferase
reporter assay as described.13
Statistical analysis
All values were expressed as mean  SD. Significant dif-
ference between experimental groups were determined by
two tailed Student’s t-test using GraphPad QuickCals, an
online tool.
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Beta catenin endogenous expression and
transcriptional activity
We measured the relative endogenous levels of beta cat-
enin mRNA CTNNB1 that was significantly higher in A549
NSCLC cell compared to WI38 normal lung cell (Fig. 1A).
Elevated mRNA expression resulted in significantly higher
level of beta catenin protein in A549 cell (Fig. 1B, C).
Similarly, beta catenin protein levels were also higher in
cytosol and nucleus of A549 (Fig. 1D).
Accumulation of beta catenin in the nucleus is a directly
related to its transcriptional activity. We measured tran-
scriptional activity of beta catenin in terms of luciferase
activity of TOPFLASH TCF reporter plasmid. Transcriptional
co-activator beta catenin combines with TCF transcription
factors in the nucleus to turn on Wnt responsive genes.
Hence, increased relative luciferase activity of TOPFLASH is
related to enhanced Wnt/beta catenin signaling in terms of
enhanced transcriptional activity of beta catenin in a cell.
We observed that beta catenin transcriptional activity was
significantly higher in both 24 h and 48 h post-transfection
A549 cell than that of WI38 cell (Fig. 1E). We selected some
of the targets of Wnt/beta catenin to validate elevatedFig. 1 Beta catenin endogenous expression and transcriptiona
A549 with respect to WI38, ACTB (Actin) was the internal control (
A549 cells. Intensity analysis is normalized to Actin and displayed i
two independent experiments) show cytosolic and nuclear beta cate
24 h and 48 h) in WI38 and A549 cells shown in terms of relative lu
CCND1, BIRC5, JUN and FOSL1 mRNA levels in A549 with respect to W
blot (representative of two independent experiments) shows phosp
bar represents standard deviation. Statistical significance, *P < 0.Wnt/beta catenin signaling in A549 cell. We found that all
the target genes tested in this study (viz; MYC, CCND1,
BIRC5, JUN and FOSL1) were significantly upregulated in
A549 NSCLC cell (Fig. 1F). These genes are involved in cell
proliferation, division, survival, growth and target gene
regulation. Hence, upregulation of these genes in A549
cancer cell was justified.
Beta catenin level can be reduced if it is phosphorylated
by Gsk3 beta, because phospho-beta catenin is a target of
ubiquitin-proteasomal pathway of protein degradation.15
However, we documented that overall phospho-beta cat-
enin (Serine 33) level in A549 was much lower than WI38
(Fig. 1G). Again, undegraded phosphorylated (Serine 33)
beta catenin is transcriptionally inactive as the complex of
phospho-beta catenin (Serine 33) and LEF/TCF cannot form
ternary complex with DNA in the nucleus and hence, it
cannot switch on Wnt responsive genes.16 Hence, reduced
phospho (serine 33) beta catenin in A549 NSCLC cell in-
dicates higher overall beta catenin transcriptional activity.
Status of important negative regulators of beta
catenin: Gsk3 beta and miR-214
Gsk3 beta is a known negative regulator of cytosolic beta
catenin level and its nuclear activity. In absence of Wntl activity. (A) Normalized fold change of CTNNB1 mRNA level in
n Z 3). (B) Western blot shows beta catenin levels in WI38 and
n bar diagram (nZ 3) (C). (D) Western blots (representative of
nin levels in WI38 and A549 cells. (E) TCF reporter activities (at
ciferase activity (n Z 3). (F) Normalized fold changes of MYC,
I38, ACTB (Actin) was the internal control (nZ 3). (G) Western
ho-beta catenin (Serine 33) levels in WI38 and A549 cells. Error
05, **P < 0.01, ***P < 0.001.
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nine 41, Serine 37 and Serine 33 residues of beta catenin.15
Reduced phospho-beta catenin (Serine 33) level in A549,
prompted us to study the status of Gsk3 beta. The
expression of GSK3B mRNA was found to be significantly
lower in A549 compared to WI38 (Fig. 2A). This was re-
flected in reduced amount of Gsk3 beta protein (Fig. 2B, C).
However, we noticed that A549 cell had rather elevated
level of overall phospho-Gsk3 beta (Serine 9) (inactive
population of Gsk3 beta) (Fig. 2B, C). We measured the
ratio of phospho-Gsk3 beta to total Gsk3 beta in WI38 and
A549 cell and the ratio was significantly higher in A549
(Fig. 2D). All these imply that negative regulator Gsk3 beta
is less active and less abundant in A549 NSCLAC cell which is
beneficial for beta catenin abundance and activity.
MicroRNAs are important regulators of gene expression
and they have multiple targets in a cell. Hence, they can
act as tumor promoters or tumor suppressor. Previously, we
and also other groups showed the negative role of miR-214Fig. 2 Status of important negative regulators of beta catenin:
mRNA level in A549 with respect to WI38, ACTB (Actin) was the inte
(Serine 9) and total Gsk3 beta levels in WI38 and A549 cells. Intensit
(n Z 3) (C). (D) The ratio of normalized intensities (as obtained
(nZ 3). (E) Normalized fold change of miR-214 level in A549 with r
Western blot shows beta catenin levels in empty U61 vector and
fection samples were assayed. Intensity analysis is normalized to a
fold changes of MYC, CCND1, JUN, FOSL1, BIRC5 mRNA levels in A
plasmid. ACTB (actin) taken as internal control (nZ 3). Error bar re
**P < 0.01, ***P < 0.001.on beta catenin in different diseases.13,17 As beta catenin
level in A549 cell was higher than that of WI38, we
measured matured miR-214 expressions in these two cells
and expectedly observed significant downregulation of miR-
214 in A549 NSCLC cell (Fig. 2E). When we overexpressed
miR-214 in A549, we observed significant reduction in beta
catenin protein expression (Fig. 2F, G). Overexpression of
miR-214 in A549 cell also resulted in significant down-
regulation of beta catenin mediated Wnt responsive genes
like MYC, CCND1, JUN, FOSL1 and BIRC5 (Fig. 2H). Hence,
downregulation of miR-214 in A549 NSCLC cell supported
elevated cellular level of beta catenin.Status of important positive regulators of beta
catenin: Akt and Hsp90
Akt is a well known crucial positive regulator of beta cat-
enin as it can inhibit negative regulator Gsk3 beta byGsk3 beta and miR-214. (A) Normalized fold change of GSK3B
rnal control (nZ 3). (B) Western blots show phospho-Gsk3 beta
y analysis are normalized to Actin and displayed in bar diagram
from (C)) of phospho-Gsk3 beta (Serine 9) to total Gsk3 beta
espect to WI38, U6 snRNA was the internal control (nZ 3). (F)
miR-214-U61 plasmid transfected A549 cells. 72 hr post trans-
ctin and displayed in bar diagram (n Z 3) (G). (H) Normalized
549 cells transfected with empty U61 vector and miR-214-U61
presents standard deviation. Statistical significance, *P < 0.05,
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direct phosphorylation of beta catenin at Serine 552 posi-
tion by Akt also promotes beta catenin transcriptional ac-
tivity enhances tumor invasion.19 We studied the Akt status.
We observed significant upregulation of AKT1 at mRNA level
in A549 cell (Fig. 3A). We also found that total Akt protein
and its active form phospho-Akt (Serine 473) were
increased in A549 compared to WI38 (Fig. 3B, C).
Heat shock protein Hsp90 is known to inhibit apoptosis in
cancer cells by stabilizing and modulating the activity of
Akt.20 It has been found that Akt forms a complex with
Hsp90 beta and thereby becomes protected from being
dephosphorylated (hence inactivated) by Protein Phospha-
tase 2 A (PP2A).20 Hence Hsp90 indirectly acts as an
important positive regulator of beta catenin. Hsp90 level
was found to be in significantly higher in A549 NSCLC cell
with respect to normal cell WI38 (Fig. 3D, E). To study the
impact of Hsp90 on phospho-Akt levels in A549, weFig. 3 Status of important positive regulators of beta catenin: A
in A549 with respect to WI38, ACTB (Actin) was the internal contro
total Akt levels in WI38 and A549 cells. Intensity analysis are norm
Western blot shows endogenous Hsp90 levels in WI38 and A549 cell
diagram (nZ 3) (E). (F) Western blot shows phospho-Akt (Serine 47
AAG or vehicle (control) DMSO for 48 h. Intensity analysis is norm
Western blot shows beta catenin levels in A549 cells treated with 5
48 h. Intensity analysis is normalized to Actin and displayed in bar
Statistical significance, *P < 0.05, **P < 0.01, ***P < 0.001.inhibited Hsp90 by 500 nM 17-AAG (a Geldanamycin deriv-
ative) for 48 h in A549 and observed that Hsp90 inhibition
drastically reduced phospho-Akt (Ser 473) level in A549 lung
cancer cell (Fig. 3F, G). As active Akt (phosphorylated at
Serine 473) is a positive regulator of beta catenin, we
extended our study to find the role of Hsp90 on beta cat-
enin level in A549. Hsp90 inhibition with 500 nM 17-AAG for
48 h in A549 cell significantly reduced beta catenin protein
level (Fig. 3H, I).
All these data indicate that upregulation of Hsp90 and
Akt (and enhanced Akt activation) were supportive to beta
catenin abundance in A549.Conclusion
We summarize that differential alterations of positive and
negative regulators can simultaneously occur in cancer tokt and Hsp90. (A) Normalized fold change of AKT1 mRNA level
l (nZ 3). (B) Western blots show phospho-Akt (Serine 473) and
alized to Actin and displayed in bar diagram (n Z 3) (C). (D)
s. Intensity analysis is normalized to Actin and displayed in bar
3) levels in A549 cells treated with 500 nM of Hsp90 inhibitor 17-
alized to Actin and displayed in bar diagram (n Z 3) (G). (H)
00 nM of Hsp90 inhibitor 17-AAG or vehicle (control) DMSO for
diagram (n Z 3) (I). Error bar represents standard deviation.
Fig. 4 Cumulative positive effect by positive and negative regulators on beta catenin level and activity in A549 NSCLC cells.
Besides direct effect of CTNNB1 (beta catenin gene) upregulation, activation and upregulation of Akt (positive regulator), upre-
gulation of Hsp90 (positive regulator) and downregulation of miR-214 (negative regulator), downregulation and inactivation of Gsk3
beta (negative regulator) had cumulative positive effect on beta catenin cellular abundance (increased level) which resulted in
increased level of Wnt responsive genes.
Activity of beta catenin in A549 287increase abundance and activity of an oncogenic protein. In
our study, downregulation and/or inhibition of negative
regulators (Gsk3 beta and miR-214) and upregulation and/
or activation of positive regulators (Akt and Hsp90) cumu-
latively increased beta catenin level and transcriptional
activity (elevated expression of Wnt responsive genes)
(Fig. 4). Our study thus suggests that consideration of reg-
ulators of oncogenic proteins might be useful in cancer
chemotherapy.Conflicts of interest
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